ABSTRACT
Plasma growth hormone (GH) was determined in samples obtained hourly from 1000 h to 0700 h before, and after a 3 week course of "prophylactic" cranial irradiation, in ten leukemic children who had no clinical or laboratory evidence of central nervous system involvement. The mean per hour value of GH prior to irradiation (4.1 +/- 2.4 ng/ml) was similar to that of 7 endocrinologically normal children (4.09 +/- 2.4 ng/ml), a finding strongly suggesting normal pituitary function prior to irradiation. Following irradiation GH levels at each hour were, in general, lower than before. The difference is statistically significant at 0100 h. The peak GH responses were lower following than preceeding irradiation (p less than 0.02). The findings suggest an immediate suppressive effect of irradiadiation on the apparently normal hypothalamic pituitary axis in children.
Subject(s)
Growth Hormone/blood , Head/radiation effects , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Leukemia/radiotherapy , Male , Pituitary Gland/radiation effectsABSTRACT
The 24 hr variations of plasma growth hormone (GH) and/or GH secretion provoked by oral glucose load or by insulin-induced hypoglycemia were studied in five microcephalic children. Low levels of GH and, especially, complete lack of secretory episodes were detected in three of the five children, two of whom were brothers. GH deficiency may constitute the principal or a contributing factor of impaired growth in some microcephalic children. A possible association between the cerebral abnomality and the pituitary hypofunction is suggested. An analogy is made between the present cases and the neuroendocrine complexes reported as Kallmann's and de Morsier's syndromes, respectively.
Subject(s)
Growth Hormone/deficiency , Microcephaly/physiopathology , Child , Circadian Rhythm , Clinical Trials as Topic , Female , Glucose , Growth Disorders/etiology , Growth Hormone/blood , Growth Hormone/metabolism , Humans , Insulin , Iodine Radioisotopes , Male , Microcephaly/complications , Pituitary Gland/physiopathologyABSTRACT
A new "bone seeking" agent, namely the organic compound diphosphonate labeled with Tc99m was tried in 21 patients for skeletal scanning. In 3 cases, although the clinical and roentgenographic evidence of bone lesions was absent, bone metastases were found, and these were confirmed histologically. The organic diphosphonate is more stable compared to the inorganic polyphosphates and the images obtained are excellent.
